Wen-Hsin Chang Selected Research

aristolactam BII

1/2021

Bioactivities and action mechanisms of active compounds from Hottuynia cordata Thunb on human lung cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wen-Hsin Chang Research Topics

Disease

13	Neoplasms (Cancer) 10/2021 - 01/2011
4	Neoplasm Metastasis (Metastasis) 01/2022 - 02/2011
4	Carcinogenesis 01/2022 - 01/2016
3	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2016
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2019 - 02/2011
2	Infections 04/2015 - 01/2013
2	Leukemia 09/2012 - 12/2011
1	Prostatic Neoplasms (Prostate Cancer) 10/2021
1	Carcinoma (Carcinomatosis) 01/2021
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2021
1	Melanoma (Melanoma, Malignant) 12/2020
1	Metabolic Diseases (Metabolic Disease) 01/2019
1	Fabry Disease (Fabry's Disease) 01/2017
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2016
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2016
1	Stomach Neoplasms (Stomach Cancer) 07/2015
1	Bacterial Infections (Bacterial Infection) 01/2013
1	Fistula 01/2013
1	Hyperlipidemias (Hyperlipidemia) 04/2011
1	Type 2 Diabetes Mellitus (MODY) 04/2011
1	Cardiovascular Diseases (Cardiovascular Disease) 04/2011
1	Insulin Resistance 04/2011
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 02/2011
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2011
1	AIDS-Related Complex (ARC) 01/2011
1	Mouth Neoplasms (Oral Cancer) 01/2011
1	Hepatocellular Carcinoma (Hepatoma) 01/2011
1	Genomic Instability 01/2003

Drug/Important Bio-Agent (IBA)

4	Amiloride (Midamor)FDA LinkGeneric 01/2019 - 01/2011
4	Histones (Histone)IBA 01/2017 - 01/2011
3	RNA (Ribonucleic Acid)IBA 12/2016 - 01/2011
2	Biomarkers (Surrogate Marker)IBA 10/2021 - 07/2015
2	DNA (Deoxyribonucleic Acid)IBA 10/2021 - 01/2003
2	Insulin (Novolin)FDA Link 01/2019 - 04/2011
2	EnzymesIBA 01/2019 - 12/2011
2	Biological ProductsIBA 01/2017 - 09/2012
2	Messenger RNA (mRNA)IBA 01/2016 - 01/2011
2	Small Interfering RNA (siRNA)IBA 01/2016 - 02/2011
1	5'-methylthioadenosine phosphorylase (methylthioadenosine nucleosidase)IBA 01/2022
1	VimentinIBA 01/2022
1	Capsules (Microcapsules)IBA 10/2021
1	HydrogelsIBA 10/2021
1	MicroRNAs (MicroRNA)IBA 10/2021
1	aristolactam BIIIBA 01/2021
1	tyrosine receptor (receptor, tyrosine)IBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 12/2020
1	matrigelIBA 12/2020
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	Taurine FDA Link 01/2016
1	Long Noncoding RNAIBA 01/2016
1	Trastuzumab (Herceptin)FDA Link 07/2015
1	Pharmaceutical PreparationsIBA 07/2015
1	Epidermal Growth Factor (EGF)IBA 07/2015
1	16S Ribosomal RNAIBA 01/2013
1	Aurora KinasesIBA 07/2011
1	LipidsIBA 04/2011
1	Glucose (Dextrose)FDA LinkGeneric 04/2011
1	squamocinIBA 02/2011
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 02/2011
1	N-nitroso-N-methyltyramine (NNMT)IBA 02/2011
1	Nicotinamide N-MethyltransferaseIBA 02/2011
1	Complementary DNA (cDNA)IBA 02/2011
1	Antihypertensive Agents (Antihypertensives)IBA 01/2011
1	Imatinib Mesylate (Gleevec)FDA Link 01/2011
1	AlkaloidsIBA 01/2011
1	Histone MethyltransferasesIBA 01/2011
1	AcetyltransferasesIBA 01/2011
1	Arecoline (Arecolin)IBA 01/2011
1	HeterochromatinIBA 01/2011

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 01/2021 - 07/2011
2	Therapeutics 01/2011 - 01/2011
1	Arthroplasty 04/2015
1	Prostheses and Implants (Prosthesis) 01/2013
1	Joint Prosthesis 01/2013
1	Glycemic Control 04/2011